Baqsimi™ (glucagon) nasal powder


This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

BAQSIMI™ (glucagon) nasal powder: Description

Baqsimi (glucagon nasal powder) is a glucagon dry nasal powder delivered via a ready-to-use nasal dosing device.

Detailed Information

Baqsimi is a 3-mg glucagon dry nasal powder. It is delivered via a nasal dosing device that

  • is ready to use and requires no reconstitution

  • is a compact, portable, single-use, drug-device combination, and 

  • does not require a person to inhale.1,2

Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1

Enclosed Prescribing Information

BAQSIMI™ (glucagon) nasal powder, for intranasal use, Lilly


1. Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

2. Baqsimi [instructions for use]. Indianapolis, IN: Eli Lilly and Company; 2019.


Baqsimi = Baqsimi™ (glucagon) nasal powder

Date of Last Review: July 24, 2019

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical